Chamberlain College of Nursing | NR 566 Advanced Pharmacology for Care of the Family
NR 566 Advanced Pharmacology for Care
of the Family Midterm Examination
2026/2027 | Verified Questions
Chamberlain College of Nursing | NR 566 Advanced Pharmacology for Care of the Family | University-
Level Advanced Practice Nursing Students
100 Verified Questions | 4 Core Domains | Academic Year 2026/2027
Prepared by
Chamberlain College of Nursing | NR 566 Advanced Pharmacology for Care of the Family
Midterm Comprehensive Examination Actual Exam | Academic Year 2026/2027
NR 566 Advanced Pharmacology for Care of the Family Midterm Examination 2026/2027 | Verified Questions
,INTRODUCTION
This comprehensive examination contains 100 original verified questions designed for university-level
advanced nursing students preparing for the NR 566 Advanced Pharmacology for Care of the Family
Midterm Examination. The questions are distributed equally across four core domains: Pharmacologic
Principles and Pharmacokinetics (25 questions), Cardiovascular and Respiratory Pharmacology (25
questions), Neurological, Psychiatric, and Pain Management Pharmacology (25 questions), and
Endocrine, Gastrointestinal, and Musculoskeletal Pharmacology (25 questions). Content is original and
structured to reinforce official Chamberlain College of Nursing NR 566 course objectives for actual exam
readiness and clinical proficiency, aligned to the 2026/2027 academic year. Each question includes a
correct answer and a clinical rationale grounded in pharmacokinetic principles, prescribing guidelines,
and evidence-based pharmacotherapeutics.
ACTUAL QUESTIONS
Domain 1: Pharmacologic Principles and Pharmacokinetics
Question 1. First-pass metabolism refers to:
A. Metabolism that occurs after a drug reaches systemic circulation
B. Extensive metabolism of an orally administered drug by the liver before it reaches systemic
circulation
C. Renal excretion of unchanged drug
D. Protein binding in plasma only
Correct Answer: A
Rationale: First-pass (presystemic) metabolism occurs when an orally absorbed drug is metabolized by
intestinal or hepatic enzymes before entering the systemic circulation, reducing bioavailability.
Question 2. Which cytochrome P450 enzyme metabolizes a large number of psychotropic
and cardiovascular medications and is subject to significant genetic polymorphism?
A. CYP1A2 only
B. CYP2D6
C. CYP2C19 exclusively
D. CYP3A4 only
Correct Answer: C
Rationale: CYP2D6 metabolizes many commonly prescribed drugs; polymorphisms produce poor,
intermediate, extensive, or ultrarapid metabolizer phenotypes that affect plasma levels and response.
Question 3. The term half-life of a drug describes:
A. The time required for the drug to reach steady state
B. The time required for the plasma concentration of the drug to decrease by 50 percent
C. The duration of clinical effect only
D. The time to peak plasma concentration
Correct Answer: A
Rationale: Elimination half-life is the time needed for the plasma concentration (or amount of drug in
the body) to fall by one-half and guides dosing interval decisions.
Question 4. Steady-state plasma concentration of a drug is generally achieved after
approximately how many half-lives?
A. One half-life
B. Two half-lives
C. Four to five half-lives
D. Ten half-lives
NR 566 Advanced Pharmacology for Care of the Family Midterm Examination 2026/2027 | Verified Questions
, Correct Answer: B
Rationale: With repeated dosing at a fixed interval, steady state is reached after about four to five half-
lives when the rate of administration equals the rate of elimination.
Question 5. Protein binding of a drug is clinically important because:
A. Only the unbound (free) fraction is pharmacologically active and available for distribution and
clearance
B. Bound drug is the only form that crosses the blood-brain barrier
C. Protein binding has no effect on drug interactions
D. All drugs are 100 percent unbound
Correct Answer: D
Rationale: Only free drug can interact with receptors or be metabolized/excreted; displacement from
protein-binding sites by other drugs can transiently increase free concentration.
Question 6. Volume of distribution (Vd) is high when:
A. The drug remains largely in the plasma
B. The drug extensively distributes into tissues outside the plasma compartment
C. The drug is not lipid soluble
D. The drug is rapidly excreted by the kidneys
Correct Answer: B
Rationale: A large Vd indicates that the drug leaves the plasma and concentrates in tissues, often
correlating with high lipophilicity.
Question 7. Which of the following best describes pharmacodynamics?
A. The study of how the body absorbs, distributes, metabolizes, and excretes a drug
B. The study of the biochemical and physiologic effects of drugs and their mechanisms of action
C. The study of genetic variations affecting drug response only
D. The study of drug manufacturing processes
Correct Answer: A
Rationale: Pharmacodynamics concerns what the drug does to the body (receptor binding, signal
transduction, therapeutic and adverse effects), in contrast to pharmacokinetics.
Question 8. A prodrug is best defined as:
A. A drug that is active upon administration and requires no metabolism
B. An inactive (or less active) compound that must be metabolically converted to the active moiety
C. A drug that is never used in clinical care
D. A drug that always has a longer half-life than its active metabolite
Correct Answer: C
Rationale: A prodrug is pharmacologically inactive until it undergoes biotransformation to release the
active drug.
Question 9. Which factor most directly influences the bioavailability of an orally
administered drug?
A. Only the color of the tablet
B. Extent of absorption and first-pass metabolism
C. The client’s preferred pharmacy
D. The time of day the prescription is written
Correct Answer: D
Rationale: Bioavailability is the fraction of the administered dose that reaches systemic circulation
unchanged and is reduced by incomplete absorption and first-pass metabolism.
NR 566 Advanced Pharmacology for Care of the Family Midterm Examination 2026/2027 | Verified Questions
NR 566 Advanced Pharmacology for Care
of the Family Midterm Examination
2026/2027 | Verified Questions
Chamberlain College of Nursing | NR 566 Advanced Pharmacology for Care of the Family | University-
Level Advanced Practice Nursing Students
100 Verified Questions | 4 Core Domains | Academic Year 2026/2027
Prepared by
Chamberlain College of Nursing | NR 566 Advanced Pharmacology for Care of the Family
Midterm Comprehensive Examination Actual Exam | Academic Year 2026/2027
NR 566 Advanced Pharmacology for Care of the Family Midterm Examination 2026/2027 | Verified Questions
,INTRODUCTION
This comprehensive examination contains 100 original verified questions designed for university-level
advanced nursing students preparing for the NR 566 Advanced Pharmacology for Care of the Family
Midterm Examination. The questions are distributed equally across four core domains: Pharmacologic
Principles and Pharmacokinetics (25 questions), Cardiovascular and Respiratory Pharmacology (25
questions), Neurological, Psychiatric, and Pain Management Pharmacology (25 questions), and
Endocrine, Gastrointestinal, and Musculoskeletal Pharmacology (25 questions). Content is original and
structured to reinforce official Chamberlain College of Nursing NR 566 course objectives for actual exam
readiness and clinical proficiency, aligned to the 2026/2027 academic year. Each question includes a
correct answer and a clinical rationale grounded in pharmacokinetic principles, prescribing guidelines,
and evidence-based pharmacotherapeutics.
ACTUAL QUESTIONS
Domain 1: Pharmacologic Principles and Pharmacokinetics
Question 1. First-pass metabolism refers to:
A. Metabolism that occurs after a drug reaches systemic circulation
B. Extensive metabolism of an orally administered drug by the liver before it reaches systemic
circulation
C. Renal excretion of unchanged drug
D. Protein binding in plasma only
Correct Answer: A
Rationale: First-pass (presystemic) metabolism occurs when an orally absorbed drug is metabolized by
intestinal or hepatic enzymes before entering the systemic circulation, reducing bioavailability.
Question 2. Which cytochrome P450 enzyme metabolizes a large number of psychotropic
and cardiovascular medications and is subject to significant genetic polymorphism?
A. CYP1A2 only
B. CYP2D6
C. CYP2C19 exclusively
D. CYP3A4 only
Correct Answer: C
Rationale: CYP2D6 metabolizes many commonly prescribed drugs; polymorphisms produce poor,
intermediate, extensive, or ultrarapid metabolizer phenotypes that affect plasma levels and response.
Question 3. The term half-life of a drug describes:
A. The time required for the drug to reach steady state
B. The time required for the plasma concentration of the drug to decrease by 50 percent
C. The duration of clinical effect only
D. The time to peak plasma concentration
Correct Answer: A
Rationale: Elimination half-life is the time needed for the plasma concentration (or amount of drug in
the body) to fall by one-half and guides dosing interval decisions.
Question 4. Steady-state plasma concentration of a drug is generally achieved after
approximately how many half-lives?
A. One half-life
B. Two half-lives
C. Four to five half-lives
D. Ten half-lives
NR 566 Advanced Pharmacology for Care of the Family Midterm Examination 2026/2027 | Verified Questions
, Correct Answer: B
Rationale: With repeated dosing at a fixed interval, steady state is reached after about four to five half-
lives when the rate of administration equals the rate of elimination.
Question 5. Protein binding of a drug is clinically important because:
A. Only the unbound (free) fraction is pharmacologically active and available for distribution and
clearance
B. Bound drug is the only form that crosses the blood-brain barrier
C. Protein binding has no effect on drug interactions
D. All drugs are 100 percent unbound
Correct Answer: D
Rationale: Only free drug can interact with receptors or be metabolized/excreted; displacement from
protein-binding sites by other drugs can transiently increase free concentration.
Question 6. Volume of distribution (Vd) is high when:
A. The drug remains largely in the plasma
B. The drug extensively distributes into tissues outside the plasma compartment
C. The drug is not lipid soluble
D. The drug is rapidly excreted by the kidneys
Correct Answer: B
Rationale: A large Vd indicates that the drug leaves the plasma and concentrates in tissues, often
correlating with high lipophilicity.
Question 7. Which of the following best describes pharmacodynamics?
A. The study of how the body absorbs, distributes, metabolizes, and excretes a drug
B. The study of the biochemical and physiologic effects of drugs and their mechanisms of action
C. The study of genetic variations affecting drug response only
D. The study of drug manufacturing processes
Correct Answer: A
Rationale: Pharmacodynamics concerns what the drug does to the body (receptor binding, signal
transduction, therapeutic and adverse effects), in contrast to pharmacokinetics.
Question 8. A prodrug is best defined as:
A. A drug that is active upon administration and requires no metabolism
B. An inactive (or less active) compound that must be metabolically converted to the active moiety
C. A drug that is never used in clinical care
D. A drug that always has a longer half-life than its active metabolite
Correct Answer: C
Rationale: A prodrug is pharmacologically inactive until it undergoes biotransformation to release the
active drug.
Question 9. Which factor most directly influences the bioavailability of an orally
administered drug?
A. Only the color of the tablet
B. Extent of absorption and first-pass metabolism
C. The client’s preferred pharmacy
D. The time of day the prescription is written
Correct Answer: D
Rationale: Bioavailability is the fraction of the administered dose that reaches systemic circulation
unchanged and is reduced by incomplete absorption and first-pass metabolism.
NR 566 Advanced Pharmacology for Care of the Family Midterm Examination 2026/2027 | Verified Questions
